Association of advanced lung cancer inflammation index with all-cause and cardiovascular mortality in metabolic dysfunction associated steatotic liver disease
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 29, 2025
Language: Английский
Epithelial barrier hypothesis in the context of nutrition, microbial dysbiosis, and immune dysregulation in metabolic dysfunction-associated steatotic liver
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 14, 2025
In
recent
years,
the
prevalence
of
chronic
liver
diseases,
particularly
Metabolic
Dysfunction-Associated
Steatotic
Liver
Disease
(MASLD),
has
increased
significantly.
This
upward
trend
is
largely
associated
with
lifestyle-related
factors
such
as
unhealthy
dietary
habits,
physical
inactivity,
and
various
environmental
influences.
Among
key
elements
contributing
to
pathogenesis
MASLD,
integrity
intestinal
epithelial
barrier
emerges
a
critical
determinant,
given
its
central
role
in
maintaining
immune
homeostasis
along
gut-liver
axis.
Disruption
this
barrier,
often
driven
by
excessive
consumption
saturated
fats
refined
carbohydrates
combination
low
fiber
intake,
can
lead
microbial
dysbiosis.
imbalance
gut
microbiota
triggers
dysregulation
promotes
systemic
inflammation,
thereby
exacerbating
hepatic
injury.
review
discusses
contribution
dysfunction
development
progression
particular
focus
on
how
permeability
may
initiate
sustain
inflammation.
Additionally,
influence
integrity,
responses,
inflammatory
cascade
addressed.
A
better
understanding
complex
interplay
between
impairment,
modulation,
pathology
offer
valuable
insights
into
MASLD
pathophysiology
contribute
more
targeted
therapeutic
strategies.
Language: Английский
Advances in understanding the role of interleukins in pulmonary fibrosis (Review)
Yuqing He,
No information about this author
Xuebin Shen,
No information about this author
Kefeng Zhai
No information about this author
et al.
Experimental and Therapeutic Medicine,
Journal Year:
2024,
Volume and Issue:
29(2)
Published: Nov. 28, 2024
Pulmonary
fibrosis
(PF)
is
a
progressive,
irreversible
disease
characterized
by
heterogeneous
interstitial
lung
tissue
damage.
It
originates
from
persistent
or
repeated
epithelial
injury
and
leads
to
the
activation
differentiation
of
fibroblasts
into
myofibroblasts.
Interleukins
(ILs)
are
group
lymphokines
crucial
for
immunomodulation
that
implicated
in
pathogenesis
PF.
However,
different
types
ILs
exert
disparate
effects
on
In
present
review,
based
effect
PF,
classified
three
categories:
i)
Promotors
PF;
ii)
inhibitors
iii)
those
dual
Several
can
promote
PF
provoking
inflammation,
initiating
proliferation
transdifferentiation
cells,
exacerbating
injury,
while
other
inhibit
through
suppressing
expression
inflammatory
factors,
modulating
Th1/Th2
balance
autophagy.
The
review
summarizes
association
focusing
roles
mechanisms
underlying
Language: Английский